Atlas Trials

Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study

Clinical trial NCT03003273 · TERMINATED

Trial details

NCT number
NCT03003273
Sponsor
All India Institute of Medical Sciences
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Neutropenia, FebrilePediatric Cancer
Start date
2017-01-01
Primary completion
2018-12-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.